Abstract:The transforming growth factor receptor III (TβRIII) is commonly recognized as a co-receptor that promotes the binding of TGFβ family ligands to type I and type II receptors. Within the immune system, TβRIII regulates T cell development in the thymus and is differentially expressed through activation; however, its function in mature T cells is unclear. To begin addressing this question, we developed a conditional knock-out mouse with restricted TβRIII deletion in mature T cells, necessary because genomic deletion of TβRIII results in perinatal mortality. We determined that TβRIII null mice developed more severe autoimmune central nervous neuroinflammatory disease after immunization with myelin oligodendrocyte peptide (MOG 35-55 ) than wild-type littermates. The increase in disease severity in TβRIII null mice was associated with expanded numbers of CNS infiltrating IFNγ + CD4 + T cells and cells that co-express both IFNγ and IL-17 (IFNγ + /IL-17 + ), but not IL-17 alone expressing CD4 T cells compared to Tgfbr3 fl/fl wild-type controls. This led us to speculate that TβRIII may be involved in regulating conversion of encephalitogenic Th17 to Th1. To directly address this, we generated encephalitogenic Th17 and Th1 cells from wild type and TβRIII null mice for passive transfer of EAE into naïve mice. Remarkably, Th17 encephalitogenic T cells from TβRIII null induced EAE of much greater severity and earlier in onset than those from wild-type mice. The severity of EAE induced by encephalitogenic wild-type and Tgfbr3 fl/fl .dLcKCre Th1 cells were similar. Moreover, in vitro restimulation of in vivo primed Tgfbr3 fl/fl .dLcKCre T cells, under Th17 but not Th1 polarizing conditions, resulted in a significant increase of IFNγ + T cells. Altogether, our data indicate that TβRIII is a coreceptor that functions as a key checkpoint in controlling the pathogenicity of autoreactive T cells in neuroinflammation probably through regulating plasticity of Th17 T cells into pathogenic Th1 cells. Importantly, this is the first demonstration that TβRIII has an intrinsic role in T cells.

T cell restricted TGF-βR3 (betaglycan) null mice develop exacerbated experimental autoimmune encephalomyelitis (EAE) associated with expanded generation of Th1 cells

Transforming growth factor receptor III (Betaglycan) regulates the generation of pathogenic Th17 cells in EAE

TGF-β–Induced Regulatory T Cells Directly Suppress B Cell Responses Through a Noncytotoxic Mechanism

Gata3 plays a supportive role for the development of Tbet-expressing Th17 cells in EAE

Enhanced T cell proliferation, Th17 differentiation and unaltered IL-10 production lead to marginally enhanced development of experimental autoimmune encephalomyelitis in EBI3-deficient mice (114.12)

GATA3 induces the pathogenicity of Th17 cells via regulating GM-CSF expression

Dendritic Cell-Specific Disruption of TGF-β Receptor II Leads to Altered Regulatory T Cell Phenotype and Spontaneous Multiorgan Autoimmunity.

Essential Roles Of Tgf-Beta In Anti-Cd3 Antibody Therapy: Reversal Of Diabetes In Nonobese Diabetic Mice Independent Of Foxp3(+) Cd4(+) Regulatory T Cells

CD226 Attenuates Treg Suppressive Capacity Via CTLA-4 and TIGIT During EAE

Effect of the exogenous transforming growth factor β1 in mouse model of the experimental autoimmune encephalomyelitis

Role of Ifn-Gamma in Induction of Foxp3 and Conversion of Cd4(+)Cd25(-) T Cells to Cd4(+) Tregs

Mouse Ephrinb3 Augments T-Cell Signaling And Responses To T-Cell Receptor Ligation

Aberrant Toll Receptor Expression and Endotoxin Hypersensitivity in Mice Lacking a Functional TGF-β1 Signaling Pathway

TGF-β1 Inhibits Protracted-relapsing Experimental Autoimmune Encephalomyelitis by Activating Dendritic Cells

NFIL3 Deficiency Alleviates EAE Through Regulating Different Immune Cell Subsets.

TLR9 mediated regulatory B10 cell amplification following sub-total body irradiation: Implications in attenuating EAE.

Diversification and Senescence of Foxp3+ Regulatory T Cells During Experimental Autoimmune Encephalomyelitis

MicroRNAs targeting TGF‐β signaling exacerbate central nervous system autoimmunity by disrupting regulatory T cell development and function

Cd1-Dependent Regulation of Chronic Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis

Smad3 Differentially Regulates the Induction of Regulatory and Inflammatory T Cell Differentiation

BRD4 expression in microglia supports recruitment of T cells into the CNS and exacerbates EAE